Antibody Response 3 Months After 2-Dose SARS-CoV-2 mRNA Vaccination in Patients With Inflammatory Bowel Disease.

MLA

Tsipotis, Evangelos, et al. “Antibody Response 3 Months After 2-Dose SARS-CoV-2 MRNA Vaccination in Patients With Inflammatory Bowel Disease.” American Journal of Gastroenterology (Lippincott Williams & Wilkins), vol. 117, no. 5, May 2022, pp. 798–801. EBSCOhost, https://doi.org/10.14309/ajg.0000000000001668.

APA

Tsipotis, E., Frey, S., Connolly, C., Werbel, W. A., Chowdhury, R., Dudley-Brown, S., Melia, J. M., Parian, A. M., Truta, B., Yu, H., Selaru, F. M., Segev, D. L., & Lazarev, M. (2022). Antibody Response 3 Months After 2-Dose SARS-CoV-2 mRNA Vaccination in Patients With Inflammatory Bowel Disease. American Journal of Gastroenterology (Lippincott Williams & Wilkins), 117(5), 798–801. https://doi.org/10.14309/ajg.0000000000001668

Chicago

Tsipotis, Evangelos, Sarah Frey, Caoilfhionn Connolly, William A. Werbel, Reezwana Chowdhury, Sharon Dudley-Brown, Joanna M. Melia, et al. 2022. “Antibody Response 3 Months After 2-Dose SARS-CoV-2 MRNA Vaccination in Patients With Inflammatory Bowel Disease.” American Journal of Gastroenterology (Lippincott Williams & Wilkins) 117 (5): 798–801. doi:10.14309/ajg.0000000000001668.